SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-22-001625
Filing Date
2022-02-14
Accepted
2022-02-14 16:00:31
Documents
1
Period of Report
2021-01-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 1322
  Complete submission text file 0001654954-22-001625.txt   2968
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 157 TECHNOLOGY DRIVE IRVINE CA 92618
Business Address
SHROTRIYA RAJESH C MD (Reporting) CIK: 0001193918 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40023 | Film No.: 22631045